Suchergebnisse - "Zhang, Liangying"

PubPharm (38)

1

Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling

enthalten in: Molecular carcinogenesis | 2024

von Zhang, S. | Zhang, L. | Zhang, D. | +15

2

Cell-permeable PI3 kinase competitive peptide inhibits KIT mutant mediated tumorigenesis of gastrointestinal stromal tumor (GIST)

enthalten in: Molecular biology reports | 2024

von Jiang, Z. | Guo, Y. | Shi, J. | +7

3

DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors

enthalten in: Molecular Carcinogenesis | 2024

von Liu, A. | Zhang, S. | Wang, M. | +14

4

DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors

enthalten in: Molecular carcinogenesis | 2024

von Liu, A. | Zhang, S. | Wang, M. | +14

5

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2023

von Li, S. | Zhao, S. | Liang, N. | +13

6

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib

enthalten in: Gastric cancer | 2023

von Li, S. | Zhao, S. | Liang, N. | +13

7

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib

enthalten in: Gastric cancer | 2023

von Li, S. | Zhao, S. | Liang, N. | +13

8

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib

enthalten in: Gastric Cancer | 2023

von Li, S. | Zhao, S. | Liang, N. | +13

9

Farnesyltransferase (FTase) Inhibitors Increase Inhibition of KIT Mutants by Imatinib

enthalten in: Reports of biochemistry & molecular biology | 2023

von Fan, Z. | Zhang, L. | Zhang, S. | +6

10

A JAK tyrosine kinase and pseudokinase Co-inhibition strategy combines enhanced potency and on-demand activation

enthalten in: European journal of medicinal chemistry | 2023

von Chen, X. | Zhang, L. | Bao, Q. | +6